DOCSLIB.ORG

Mouse Pxdn Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Pxdn Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Pxdn Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Pxdn conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Pxdn gene (NCBI Reference Sequence: NM_181395 ; Ensembl: ENSMUSG00000020674 ) is located on Mouse chromosome 12. 23 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 23 (Transcript: ENSMUST00000122328). Exon 11~13 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Pxdn gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-125H6 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for an ENU-induced allele exhibit abnormal eye development with early-onset glaucoma and progressive retinal dysgenesis. Exon 11 starts from about 28.99% of the coding region. The knockout of Exon 11~13 will result in frameshift of the gene. The size of intron 10 for 5'-loxP site insertion: 2365 bp, and the size of intron 13 for 3'-loxP site insertion: 1048 bp. The size of effective cKO region: ~2511 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 11 12 13 14 23 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Pxdn Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(9011bp) | A(24.06% 2168) | C(22.96% 2069) | T(29.44% 2653) | G(23.54% 2121) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr12 + 29990125 29993124 3000 browser details YourSeq 81 2585 2881 3000 70.7% chr10 + 40377451 40377674 224 browser details YourSeq 71 2607 2990 3000 72.2% chr18 - 75485569 75485866 298 browser details YourSeq 68 2539 2688 3000 81.0% chr19 + 53560188 53560323 136 browser details YourSeq 59 2605 2912 3000 75.4% chr10 + 94937399 94937654 256 browser details YourSeq 58 2605 2696 3000 81.6% chr15 - 68295774 68295865 92 browser details YourSeq 52 2608 2888 3000 66.3% chr1 + 39480637 39480834 198 browser details YourSeq 49 992 1091 3000 94.7% chr1 + 38841968 38842472 505 browser details YourSeq 47 2605 2688 3000 77.3% chr5 - 100759471 100759553 83 browser details YourSeq 47 2605 2688 3000 86.0% chr6 + 88746721 88746802 82 browser details YourSeq 47 218 338 3000 87.1% chr1 + 72385416 72385534 119 browser details YourSeq 46 1249 1312 3000 92.8% chr18 - 55473993 55474057 65 browser details YourSeq 45 215 344 3000 92.6% chrX - 16463167 16463297 131 browser details YourSeq 45 2592 2667 3000 80.3% chr16 + 21287336 21287427 92 browser details YourSeq 43 2516 2671 3000 91.5% chr6 - 82360468 82360622 155 browser details YourSeq 43 2598 2671 3000 79.8% chr2 - 156804001 156804088 88 browser details YourSeq 43 1010 1095 3000 93.9% chr10 - 114975306 114975442 137 browser details YourSeq 43 2592 2671 3000 77.5% chr10 + 9983167 9983262 96 browser details YourSeq 43 2609 2688 3000 77.5% chr1 + 138178644 138178722 79 browser details YourSeq 42 202 340 3000 88.9% chr6 - 38407530 38407668 139 Note: The 3000 bp section upstream of Exon 11 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr12 + 29995636 29998635 3000 browser details YourSeq 98 3 124 3000 87.4% chr10 + 62933411 62933529 119 browser details YourSeq 95 14 2492 3000 88.0% chr10 - 121478380 121799252 320873 browser details YourSeq 95 1 124 3000 91.4% chr8 + 120099254 120099377 124 browser details YourSeq 95 1 111 3000 92.8% chr10 + 26474572 26474682 111 browser details YourSeq 91 1 112 3000 91.1% chr10 - 128162178 128162291 114 browser details YourSeq 89 3 133 3000 87.4% chr19 + 45610334 45610782 449 browser details YourSeq 88 10 112 3000 93.3% chr6 - 117895192 117895296 105 browser details YourSeq 88 1 112 3000 87.4% chr1 + 72305051 72305161 111 browser details YourSeq 87 10 125 3000 86.4% chr1 + 179645538 179645650 113 browser details YourSeq 86 1 107 3000 90.7% chr10 - 18008972 18398790 389819 browser details YourSeq 85 1 112 3000 88.4% chr8 - 120390102 120390215 114 browser details YourSeq 84 1 108 3000 88.9% chr11 - 4589774 4589881 108 browser details YourSeq 84 1 124 3000 84.3% chr10 + 39715469 39715592 124 browser details YourSeq 84 1 112 3000 87.5% chr1 + 106411480 106411591 112 browser details YourSeq 83 1 107 3000 88.8% chr1 - 60608633 60608739 107 browser details YourSeq 82 13 122 3000 89.6% chr18 + 42156397 42156506 110 browser details YourSeq 81 1 112 3000 83.7% chr10 - 111568126 111568235 110 browser details YourSeq 81 1 111 3000 86.5% chr1 - 63209056 63209166 111 browser details YourSeq 80 7 107 3000 90.1% chr10 + 81241420 81241532 113 Note: The 3000 bp section downstream of Exon 13 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Pxdn peroxidasin [ Mus musculus (house mouse) ] Gene ID: 69675, updated on 12-Aug-2019 Gene summary Official Symbol Pxdn provided by MGI Official Full Name peroxidasin provided by MGI Primary source MGI:MGI:1916925 See related Ensembl:ENSMUSG00000020674 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as VPO1; C85409; mKIAA0230; E330004E07; 2310075M15Rik Expression Broad expression in subcutaneous fat pad adult (RPKM 54.0), limb E14.5 (RPKM 52.0) and 21 other tissues See more Orthologs human all Genomic context Location: 12; 12 A2 See Pxdn in Genome Data Viewer Exon count: 24 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 12 NC_000078.6 (29936642..30017658) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 12 NC_000078.5 (30622901..30702523) Chromosome 12 - NC_000078.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 8 transcripts Gene: Pxdn ENSMUSG00000020674 Description peroxidasin [Source:MGI Symbol;Acc:MGI:1916925] Gene Synonyms 2310075M15Rik, VPO1 Location Chromosome 12: 29,937,608-30,017,658 forward strand. GRCm38:CM001005.2 About this gene This gene has 8 transcripts (splice variants), 213 orthologues, 4 paralogues, is a member of 2 Ensembl protein families and is associated with 37 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Pxdn-202 ENSMUST00000122328.7 6614 1475aa ENSMUSP00000113703.1 Protein coding CCDS25856 Q3UQ28 TSL:1 GENCODE basic APPRIS P1 Pxdn-208 ENSMUST00000220271.1 6377 1295aa ENSMUSP00000151320.1 Protein coding - A0A1W2P6L9 TSL:5 GENCODE basic Pxdn-201 ENSMUST00000118321.2 2698 307aa ENSMUSP00000113477.2 Protein coding - D3Z5M7 TSL:1 GENCODE basic Pxdn-207 ENSMUST00000218620.1 4578 No protein - Retained intron - - TSL:5 Pxdn-206 ENSMUST00000155318.1 3406 No protein - Retained intron - - TSL:1 Pxdn-204 ENSMUST00000137316.1 787 No protein - Retained intron - - TSL:2 Pxdn-203 ENSMUST00000126233.1 768 No protein - Retained intron - - TSL:2 Pxdn-205 ENSMUST00000155190.1 1024 No protein - lncRNA - - TSL:3 100.05 kb Forward strand 29.94Mb 29.96Mb 29.98Mb 30.00Mb 30.02Mb Genes (Comprehensive set... Pxdn-208 >protein coding Pxdn-202 >protein coding Pxdn-206 >retained intron Pxdn-205 >lncRNA Pxdn-201 >protein coding Pxdn-203 >retained intron Pxdn-204 >retained intron Pxdn-207 >retained intron Contigs < AC159626.2 < AC165078.2 Regulatory Build 29.94Mb 29.96Mb 29.98Mb 30.00Mb 30.02Mb Reverse strand 100.05 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding RNA gene processed transcript Page 6 of 8 https://www.alphaknockout.com Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000122328 79.62 kb Forward strand Pxdn-202 >protein coding ENSMUSP00000113... Transmembrane heli... Low complexity (Seg) Coiled-coils (Ncoils) Cleavage site (Sign... Superfamily Immunoglobulin-like domain superfamily Haem peroxidase superfamily SSF57603 SSF52058 SMART Immunoglobulin subtype 2 VWFC domain Immunoglobulin subtype Leucine-rich repeat, typical subtype Cysteine-rich flanking region,
Load more

Recommended publications
  • Environmental Influences on Endothelial Gene Expression
    ENDOTHELIAL CELL GENE EXPRESSION John Matthew Jeff Herbert Supervisors: Prof. Roy Bicknell and Dr. Victoria Heath PhD thesis University of Birmingham August 2012 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Tumour angiogenesis is a vital process in the pathology of tumour development and metastasis. Targeting markers of tumour endothelium provide a means of targeted destruction of a tumours oxygen and nutrient supply via destruction of tumour vasculature, which in turn ultimately leads to beneficial consequences to patients. Although current anti -angiogenic and vascular targeting strategies help patients, more potently in combination with chemo therapy, there is still a need for more tumour endothelial marker discoveries as current treatments have cardiovascular and other side effects. For the first time, the analyses of in-vivo biotinylation of an embryonic system is performed to obtain putative vascular targets. Also for the first time, deep sequencing is applied to freshly isolated tumour and normal endothelial cells from lung, colon and bladder tissues for the identification of pan-vascular-targets. Integration of the proteomic, deep sequencing, public cDNA libraries and microarrays, delivers 5,892 putative vascular targets to the science community.
    [Show full text]
  • In-House Production Method for DNA Ladders to Determine Nucleotide Fragment Sizes up to 1500 Base Pairs
    International Journal of New Technology and Research (IJNTR) ISSN:2454-4116, Volume-3, Issue-11, November 2017 Pages 66-70 In-house Production Method for DNA Ladders to Determine Nucleotide Fragment Sizes up to 1500 Base Pairs Tengis A1*, Duuriimaa.O2*, Badamsuren B2, Batchimeg N3, Ulziijargal G3, Tsendmaa TS1, Javkhlan B1, Baigalmaa B1, Bilegtsaikhan TS1, Munkhtulga L1, Nyambayar D1, Munkhbat B1 Baatartsogt O2 and Purevjargal N1 generated by cleavage of the native DNA with restriction Abstract — the human genome project was recently enzymes in the laboratory. Commercially, a broad range of completed after running for 15 years and revealed the presence DNA ladders from numerous suppliers are available in the of 30,000 genes in the human genome with a total nucleotide market with relatively high prices. This study aimed to length of 3.2 billion base pairs (bp). Many novel methods and produce a DNA ladder in house at a cheaper price. techniques have been developed in the field of molecular biology Here, we describe a method to produce a 100 bp DNA and molecular genetics as a result of intensive research, where size marker, which minimizes the experimental basic analysis is impossible without the use of DNA size markers or DNA ladders. This research aimed to establish an in-house disadvantages mentioned above. Based on our protocol, any method to produce DNA size markers detecting up to 1500 bp laboratory can prepare its own 100 bp DNA size marker. size. DNA size markers are commonly used consumables in molecular biology laboratories. In this study, we report II. MATERIALS AND METHODS preparation of a DNA size marker consisting of 12 fragments The cloning vector pDyne TA V2, Dyne Agarose STAR, from 100 to 1500 bp.
    [Show full text]
  • Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth
    ORIGINAL www.jpeds.com • THE JOURNAL OF PEDIATRICS ARTICLES Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth Joan Kaufman, PhD1,2,3, Janitza L. Montalvo-Ortiz, PhD3, Hannah Holbrook,BA4, Kerry O'Loughlin,BA4, Catherine Orr, PhD4, Catherine Kearney,MA1, Bao-Zhu Yang, PhD3, Tao Wang, PhD5,6, Hongyu Zhao, PhD5, Robert Althoff, MD, PhD4, Hugh Garavan, PhD4, Joel Gelernter,MD3,7, and James Hudziak,MD4 Objective To determine if measures of adverse childhood experiences and DNA methylation relate to indices of obesity in youth. Study design Participants were derived from a cohort of 321 8 to 15-year-old children recruited for an investi- gation examining risk and resilience and psychiatric outcomes in maltreated children. Assessments of obesity were collected as an add-on for a subset of 234 participants (56% female; 52% maltreated). Illumina arrays were used to examine whole genome epigenetic predictors of obesity in saliva DNA. For analytic purposes, the cohort ana- lyzed in the first batch comprised the discovery sample (n = 160), and the cohort analyzed in the second batch the replication sample (n = 74). Results After controlling for race, sex, age, cell heterogeneity, 3 principal components, and whole genome testing, 10 methylation sites were found to interact with adverse childhood experiences to predict cross-sectional mea- sures of body mass index, and an additional 6 sites were found to exert a main effect in predicting body mass index (P < 5.0 × 10−7, all comparisons). Eight of the methylation sites were in genes previously associated with obesity risk (eg, PCK2, CxCl10, BCAT1, HID1, PRDM16, MADD, PXDN, GALE), with several of the findings from the dis- covery data set replicated in the second cohort.
    [Show full text]
  • Homozygous Mutations in PXDN Cause Congenital Cataract, Corneal Opacity, and Developmental Glaucoma
    REPORT Homozygous Mutations in PXDN Cause Congenital Cataract, Corneal Opacity, and Developmental Glaucoma Kamron Khan,1,2,11 Adam Rudkin,3,11 David A. Parry,1,11 Kathryn P. Burdon,3 Martin McKibbin,1,2 Clare V. Logan,1 Zakia I.A. Abdelhamed,1,4 James S. Muecke,5 Narcis Fernandez-Fuentes,1 Kate J. Laurie,3 Mike Shires,1 Rhys Fogarty,3 Ian M. Carr,1 James A. Poulter,1 Joanne E. Morgan,1 Moin D. Mohamed,1,6 Hussain Jafri,7 Yasmin Raashid,8 Ngy Meng,9 Horm Piseth,10 Carmel Toomes,1 Robert J. Casson,5 Graham R. Taylor,1 Michael Hammerton,5 Eamonn Sheridan,1 Colin A. Johnson,1 Chris F. Inglehearn,1 Jamie E. Craig,3,11,* and Manir Ali1,11,* Anterior segment dysgenesis describes a group of heterogeneous developmental disorders that affect the anterior chamber of the eye and are associated with an increased risk of glaucoma. Here, we report homozygous mutations in peroxidasin (PXDN) in two consanguineous Pakistani families with congenital cataract-microcornea with mild to moderate corneal opacity and in a consanguineous Cambodian family with developmental glaucoma and severe corneal opacification. These results highlight the diverse ocular phenotypes caused by PXDN mutations, which are likely due to differences in genetic background and environmental factors. Peroxidasin is an extracellular matrix-associated protein with peroxidase catalytic activity, and we confirmed localization of the protein to the cornea and lens epithe- lial layers. Our findings imply that peroxidasin is essential for normal development of the anterior chamber of the eye, where it may have a structural role in supporting cornea and lens architecture as well as an enzymatic role as an antioxidant enzyme in protecting the lens, trabecular meshwork, and cornea against oxidative damage.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
    Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.
    [Show full text]
  • Targets of the Tumor Suppressor Mir-200 in Regulation of the Epithelial–Mesenchymal Transition in Cancer
    Published OnlineFirst October 10, 2011; DOI: 10.1158/0008-5472.CAN-11-0964 Cancer Tumor and Stem Cell Biology Research Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial–Mesenchymal Transition in Cancer Mark J. Schliekelman1 , Don L. Gibbons2,3, Vitor M. Faca1, Chad J. Creighton4, Zain H. Rizvi2, Qing Zhang1, Chee-Hong Wong1, Hong Wang1, Christin Ungewiss2, Young-Ho Ahn2, Dong-Hoon Shin2, Jonathan M. Kurie2, and Samir M. Hanash1 Abstract The microRNA-200 (miR-200) family restricts epithelial–mesenchymal transition (EMT) and metastasis in tumor cell lines derived from mice that develop metastatic lung adenocarcinoma. To determine the mechanisms responsible for EMT and metastasis regulated by this microRNA, we conducted a global liquid chromatography/ tandem mass spectrometry analysis to compare metastatic and nonmetastatic murine lung adenocarcinoma cells which had undergone EMT because of loss of miR-200. An analysis of syngeneic tumors generated by these cells identified multiple novel proteins linked to metastasis. In particular, the analysis of conditioned media, cell surface proteins, and whole-cell lysates from metastatic and nonmetastatic cells revealed large-scale modifica- tions in the tumor microenvironment. Specific increases were documented in extracellular matrix (ECM) proteins, peptidases, and changes in distribution of cell adhesion proteins in the metastatic cell lines. Integrating proteomic data from three subproteomes, we defined constituents of a multilayer protein network that both regulated and mediated the effects of TGFb. Lastly, we identified ECM proteins and peptidases that were directly regulated by miR-200. Taken together, our results reveal how expression of miR-200 alters the tumor microenvironment to inhibit the processes of EMT and metastasis.
    [Show full text]
  • Transcriptome Analysis of Human Cancer Reveals a Functional Role Of
    Tauber et al. Molecular Cancer 2010, 9:200 http://www.molecular-cancer.com/content/9/1/200 RESEARCH Open Access Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion Stefanie Tauber1,2†, Alexander Jais1†, Markus Jeitler1, Sandra Haider3, Julia Husa1, Josefine Lindroos1, Martin Knöfler3, Matthias Mayerhofer1, Hubert Pehamberger4, Oswald Wagner1, Martin Bilban1* Abstract Background: Heme Oxygenase-1 (HO-1) is expressed in many cancers and promotes growth and survival of neoplastic cells. Recently, HO-1 has been implicated in tumor cell invasion and metastasis. However, the molecular mechanisms underlying these biologic effects of HO-1 remain largely unknown. To identify a common mechanism of action of HO-1 in cancer, we determined the global effect of HO-1 on the transcriptome of multiple tumor entities and identified a universal HO-1-associated gene expression signature. Results: Genome-wide expression profiling of Heme Oxygenase-1 expressing versus HO-1 silenced BeWo choriocarcinoma cells as well as a comparative meta-profiling of the preexisting expression database of 190 human tumors of 14 independent cancer types led to the identification of 14 genes, the expression of which correlated strongly and universally with that of HO-1 (P = 0.00002). These genes included regulators of cell plasticity and extracellular matrix (ECM) remodeling (MMP2, ADAM8, TGFB1, BGN, COL21A1, PXDN), signaling (CRIP2, MICB), amino acid transport and glycosylation (SLC7A1 and ST3GAL2), estrogen and phospholipid biosynthesis (AGPAT2 and HSD17B1), protein stabilization (IFI30), and phosphorylation (ALPPL2). We selected PXDN, an adhesion molecule involved in ECM formation, for further analysis and functional characterization.
    [Show full text]
  • Mouse Models for Microphthalmia, Anophthalmia and Cataracts
    Human Genetics https://doi.org/10.1007/s00439-019-01995-w ORIGINAL INVESTIGATION Mouse models for microphthalmia, anophthalmia and cataracts Jochen Graw1 Received: 16 November 2018 / Accepted: 4 March 2019 © The Author(s) 2019 Abstract Mouse mutants are a long-lasting, valuable tool to identify genes underlying eye diseases, because the absence of eyes, very small eyes and severely affected, cataractous eyes are easily to detect without major technical equipment. In mice, actually 145 genes or loci are known for anophthalmia, 269 for microphthalmia, and 180 for cataracts. Approximately, 25% of the loci are not yet characterized; however, some of the ancient lines are extinct and not available for future research. The pheno- types of the mutants represent a continuous spectrum either in anophthalmia and microphthalmia, or in microphthalmia and cataracts. On the other side, mouse models are still missing for some genes, which have been identified in human families to be causative for anophthalmia, microphthalmia, or cataracts. Finally, the mouse offers the possibility to genetically test the roles of modifiers and the role of SNPs; these aspects open new avenues for ophthalmogenetics in the mouse. Introduction Semina 2015; Anand et al. 2018); therefore, in this review, I will concentrate on mouse models, because the mouse is Blindness in children is a very severe condition affecting ~ 14 genetically the best characterized mammalian model system million children worldwide (Solebo et al. 2017). Among for hereditary diseases, particularly, if they affect the eye. them, cataracts are the major subgroup affecting 28% of the Anophthalmia, severe microphthalmia and congenital cases (Solebo et al.
    [Show full text]
  • Current Research in Clinical Diabetes and Obesity Gunturiz ML, Et Al
    Current Research in Clinical Diabetes and Obesity Gunturiz ML, et al. Curr Res Clin Diab Obes: CRCDO-101. Review Article DOI: 10.29011/CRCDO-101/100001 Genes Implicated in Obesity and Overweight: Potential Biomarkers of Early Diagnosis María Luz Gunturiz Albarracín1*, Ana Yibby Forero2, Pablo Enrique Chaparro3 1Project Bank Team, Public Health Research Division, National Institute of Health, Colombia 2Nutrition Group, Public Health Research Division, National Institute of Health, Colombia 3National Health Observatory Division, National Institute of Health, Colombia *Corresponding author: María Luz Gunturiz Albarracín, BsC, PhD. Project Bank Team, Public Health Research Division, National Institute of Health, Avenue Street 26 No 51-20 CAN, Bogotá, D.C., Colombia. Tel: +5712207700; +573123600581; Email: mgun- [email protected] Citation: Gunturiz ML, Forero AY, Chaparro PE (2018) Genes Implicated in Obesity and Overweight: Potential Biomarkers of Early Diagnosis. Curr Res Clin Diab Obes: CRCDO-101. DOI: 10.29011/CRCDO-101/100001 Received Date: 10 October, 2018; Accepted Date: 23 October, 2018; Published Date: 30 October, 2018 Abstract Obesity is a chronic, complex and multifactorial disease, characterized by excess body fat, positive imbalance between energy intake and energy expenditure. The adverse metabolic effects caused by obesity can increase the risk of type 2 diabetes, many forms of cancer, fatty liver disease, hormonal disorders, hypertension, cardiovascular disease, metabolic syndrome and increased mortality, among others. In children, childhood obesity increases the chances of an earlier adolescence, gynecomastia in children and polycystic ovary syndrome, among other diseases; In addition, obese children and adolescents are more likely to remain obese in adulthood and develop various cardiovascular and metabolic diseases that decrease their quality of life.
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • The Meeting of the International Society for Genetic Eye Diseases & Retinoblastoma
    The Meeting of the International Society for Genetic Eye Diseases & Retinoblastoma Ghent, Belgium August 22 – 24, 2013 ISGEDR 2013 2 Welcome to Ghent and to Your Meeting … Dear Participant Allow us to wish you a very warm welcome to the wonderful city of Ghent for the 2013 Meeting of the ISGEDR. With a program filled to the brim with fantastic presentations, we are confident that you will find this meeting most stimulating. The scientific quality of the papers and posters given by the participants covers a broad spectrum of genetic eye disease and retinoblastoma. Mixed with the free papers, are a number of symposia and keynote lectures. In addition to the superb intellectual gems of the free papers and posters, the symposia and keynote lectures will most certainly update us on the latest developments in therapies for inherited retinal dystrophies, current concepts of fibrillinopathies and related disorders, recognition and management of seeding of retinoblastoma, genome-wide association studies, and how novel molecular genetic techniques influence current ophthalmic genetic practice. We are certain that you may also find the beauty of Ghent and its many cultural highlights a treat. In addition to lunch provided on site, other culinary delights include a Belgian beer tasting with assorted cheeses on Thursday evening, and a gala dinner on Saturday evening in Hôtel Falligan, the most important rococo building of Ghent, built in 1755. We hope you have a great ISGEDR 2013 Meeting! Bart P. Leroy, M.D., Ph.D. Meeting Chair, and Head of Local Organizing Committee David A. Mackey, M.D. President, ISGEDR Elias I.
    [Show full text]